TY - JOUR
T1 - Interaction between leukocytes and erythrocytes in the human retina
T2 - Effects of pentoxifylline on hyperoxia-induced vasoconstriction during increased neutrophil counts
AU - Told, Reinhard
AU - Fuchsjäger-Mayrl, Gabriele
AU - Wolzt, Michael
AU - Popa-Cherecheanu, Alina
AU - Schmetterer, Leopold
AU - Garhofer, Gerhard
PY - 2014/3
Y1 - 2014/3
N2 - Purpose: Pentoxifylline, a nonselective phosphodiesterase inhibitor, shows vasodilator effects in certain vascular beds and reduces blood viscosity. We have previously shown that under states of vasoconstriction an interaction between circulating erythrocytes and leukocytes may play a role in the control of blood flow. The reason for this observation is not entirely clear but may be related to a mechanical interaction between red and white blood cells. In the present study we hypothesized that pentoxifylline may alter this interaction during oxygen-induced vasoconstriction. Methods: 24 healthy male subjects participated in this double masked, randomized, placebo-controlled 2 way cross over trail. In order to increase white blood cell count (WBC) count, 300. μg of G-CSF was administered intravenously. Vasoconstriction of retinal vessels was induced by oxygen inhalation. 400. mg of pentoxifylline or placebo was infused at two different study days. White blood cell flux was assessed with the blue-field entoptic technique. Vessel calibers were measured with a dynamic vessel analyzer (DVA) and red blood cell velocity (RBCV) was determined with laser Doppler velocimetry (LDV). Retinal blood flow was calculated based on retinal vessel diameters and RBCV. Results: Administration of G-CSF induced a significant increase in WBC, both in the placebo and the pentoxifylline group (p< 0.01 for both groups). Retinal vessel diameter, RBCV, calculated retinal blood flow and white blood cell flow were not altered by administration of pentoxifylline. Hyperoxia induced a pronounced decrease in retinal blood flow parameters. No difference was observed between groups during oxygen breathing in vessel diameters (p= 0.54), RBCV (p= 0.34), calculated retinal blood flow (p= 0.3) and white blood cell flow (p= 0.26). Conclusion: Our data indicate that short time administration of pentoxifylline does not alter the oxygen-induced effect on ocular blood flow parameters during leukocytosis. Whether long-term treatment could improve retinal blood flow under states of vasoconstriction remains to be investigated.
AB - Purpose: Pentoxifylline, a nonselective phosphodiesterase inhibitor, shows vasodilator effects in certain vascular beds and reduces blood viscosity. We have previously shown that under states of vasoconstriction an interaction between circulating erythrocytes and leukocytes may play a role in the control of blood flow. The reason for this observation is not entirely clear but may be related to a mechanical interaction between red and white blood cells. In the present study we hypothesized that pentoxifylline may alter this interaction during oxygen-induced vasoconstriction. Methods: 24 healthy male subjects participated in this double masked, randomized, placebo-controlled 2 way cross over trail. In order to increase white blood cell count (WBC) count, 300. μg of G-CSF was administered intravenously. Vasoconstriction of retinal vessels was induced by oxygen inhalation. 400. mg of pentoxifylline or placebo was infused at two different study days. White blood cell flux was assessed with the blue-field entoptic technique. Vessel calibers were measured with a dynamic vessel analyzer (DVA) and red blood cell velocity (RBCV) was determined with laser Doppler velocimetry (LDV). Retinal blood flow was calculated based on retinal vessel diameters and RBCV. Results: Administration of G-CSF induced a significant increase in WBC, both in the placebo and the pentoxifylline group (p< 0.01 for both groups). Retinal vessel diameter, RBCV, calculated retinal blood flow and white blood cell flow were not altered by administration of pentoxifylline. Hyperoxia induced a pronounced decrease in retinal blood flow parameters. No difference was observed between groups during oxygen breathing in vessel diameters (p= 0.54), RBCV (p= 0.34), calculated retinal blood flow (p= 0.3) and white blood cell flow (p= 0.26). Conclusion: Our data indicate that short time administration of pentoxifylline does not alter the oxygen-induced effect on ocular blood flow parameters during leukocytosis. Whether long-term treatment could improve retinal blood flow under states of vasoconstriction remains to be investigated.
UR - http://www.scopus.com/inward/record.url?scp=84895921275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84895921275&partnerID=8YFLogxK
U2 - 10.1016/j.mvr.2014.01.004
DO - 10.1016/j.mvr.2014.01.004
M3 - Article
C2 - 24444783
AN - SCOPUS:84895921275
SN - 0026-2862
VL - 92
SP - 85
EP - 90
JO - Microvascular Research
JF - Microvascular Research
ER -